Page Therapeutics Appoints Meret Gaugler, PhD, to Board of Directors
BASEL, Switzerland, Oct. 25, 2024 — Page Therapeutics, a biotech company focused on tackling metastatic cancer spread at its root, is pleased to announce the appointment of Meret Gaugler, PhD, as independent member of the Board of Directors. Dr. Gaugler brings both a scientific background and nearly a decade and a half…












